Correlation between tau phosphorylation sites and tangle morphology in Alzheimer's disease

Psychogeriatrics

Volumn 5, Issue 2, 2005, Pages 22-35

  Shimazaki, Masao ^a,b   Nakano, Hiroyuki ^a,c   Kobayashi, Katsuji ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b National Hospital Organization   (Japan)

^c Kohseiren Takaoka Hospital   (Japan)

Author keywords

Alzheimer's disease; AT180; AT8; Extracellular ghost tangle; HT7; Intracellular tangle; Pretangle; Tau protein; Tau2; Tau5

Indexed keywords

MONOCLONAL ANTIBODY; SERINE; TAU 2 PROTEIN; TAU 5 PROTEIN; TAU PROTEIN; THREONINE; UNCLASSIFIED DRUG;

ADULT; ALZHEIMER DISEASE; ANTIBODY LABELING; ARTICLE; ASSOCIATION CORTEX; CINGULATE GYRUS; CONTROLLED STUDY; ENTORHINAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LIMBIC CORTEX; NEUROFIBRILLARY TANGLE; OCCIPITAL CORTEX; PARIETAL LOBE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TEMPORAL CORTEX;

EID: 27944486753     PISSN: 13463500     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-8301.2005.00087.x     Document Type: Article

References (56)

1. Augustinack JC, Schneider A, Mandelkow EM, Hyman BT. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol (Berl) 2002; 103: 26-35.
2. Brion JP, Anderton BH, Authelet M et al. Neurofibrillary tangles and tau phosphorylation. Biochem Soc Symp 2001; 67: 81-88.
3. Delacourte A, David JP, Sergeant N et al. The biochemical pathways of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 1999; 52: 1158-1165.
4. Flament S, Delacourte A, Delaere P, Duyckaerts C, Hauw JJ. Correlation between microscopical changes and Tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type. Tau 64 and 69 are reliable markers of the neurofibrillary degeneration. Acta Neuropathol (Berl) 1990; 80: 212-215.
5. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82: 239-259.
6. Augustinack JC, Sanders JL, Tsai LH, Hyman BT. Colocalization and fluorescence resonance energy transfer between cdk5 and AT8 suggests a close association in pre-neurofibrillary tangles and neurofibrillary tangles. J Neuropathol Exp Neurol 2002; 61: 557-564.
7. Braak E, Braak H, Mandelkow EM. A sequence of cytoskeletal changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol (Berl) 1994; 87: 554-567.
8. Cras P, Smith MA, Richey PL, Siedlak SL, Mulvihill P, Perry G. Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease. Acta Neuropathol (Berl) 1995; 89: 291-295.
9. Lee G. Tau protein: an update on structure and function. Cell Motil Cytoskeleton 1990; 15: 199-203.
10. Singh TJ, Zaidi T, Grundke-Iqbal I, Iqbal K. Non-proline-dependent protein kinases phosphorylate several sites found in tau from Alzheimer disease brain. Mol Cell Biochem 1996; 154: 143-151.
11. Wu JM, Chen Y, Hsieh TC, Brandt R, Lee G. Phosphorylation of native and truncated isoforms of protein tau by the double-stranded DNA-dependent protein kinase (DNA-PK) shows that the primary phosphorylation sites are localized between amino acid residues 212-231 of the longest tau. Biochem Mol Biol Int 1996; 40: 21-31.
12. Bancher C, Grundke-Iqbal I, Iqbal K, Fried VA, Smith HT, Wisniewski HM. Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease. Brain Res 1991; 539: 11-18.
13. Tolnay M, Probst A. Tau protein pathology in Alzheimer's disease and related disorders. Neuropathol Appl Neurobiol 1999; 25: 171-187.
14. Vermersch P, Frigard B, Delacourte A. Mapping of neurofibrillary degeneration in Alzheimer's disease: evaluation of heterogeneity using the quantification of abnormal tau proteins. Acta Neuropathol (Berl) 1992; 85: 48-54.
15. Goedert M, Jakes R, Crowther RA et al. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem J 1994; 301: 871-877.
16. Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody AT8 recognizes tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995; 189: 167-169.
17. Mercken M, Vandermeeren M, Lubke U et al. Affinity purification of human tau proteins and the construction of a sensitive sandwich enzyme-linked immunosorbent assay for human tau detection. J Neurochem 1992; 58: 548-553.
18. Papasozomenos SC, Binder LI. Phosphorylation determines two distinct species of tau in the central nervous system. Cell Motil Cytoskeleton 1987; 8: 210-226.
19. Papasozomenos SC. Tau protein immunoreactivity in dementia of the Alzheimertype. II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments. Lab Invest 1989; 60: 375-389.
20. Papasozomenos SC, Su Y. Rapid dephosphorylation of tau in heat-shocked fetal rat cerebral explants: prevention and hyperphosphorylation by inhibitors of protein phosphatases PP1 and PP2A. J Neurochem 1995; 65: 396-406.
21. Watanabe N, Takio K, Hasegawa M, Arai T, Titani K, Ihara Y. Tau 2: a probe for Ser conformation in the amino terminus of tau. J Neurochem 1992; 58: 960-966.
22. Kimura T, Ono T, Takamatsu J et al. Sequential changes of tau-site-specific phosphorylation during development of paired helical filaments. Dementia 1996; 7: 177-181.
23. Nakano H, Kobayashi K, Sugimori K et al. Regional analysis of differently phosphorylated tau proteins in brains from patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2004; 17: 122-131.
24. Su JH, Cummings BJ, Cotman CW. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites. Neuroreport 1994; 5: 2358-2362.
25. Yang SD, Yu JS, Liu WK, Yen SH. Synergistic control mechanism for abnormal site phosphorylation of Alzheimer's disease brain tau by kinase FA/GSK-3 alpha. Biochem Biophys Res Commun 1993; 197: 400-406.
26. Uchihara T, Nakamura A, Yamazaki M, Mori O. Evolution from pretangle neurons to neurofibrillary tangles monitored by thiazin red combined with Gallyas method and double immunofluorescence. Acta Neuropathol (Berl) 2001; 101: 535-539.
27. Kobayashi K, Muramori F, Aoki T et al. KP1 is a marker for extraneuronal neurofibrillary tangles and senile plaques in Alzheimer diseased brains. Dement Geriatr Cogn Disord 1998; 9: 13-19.
28. Schwab C, Steele JC, McGeer EG, McGeer PL. Amyloid P immunoreactivity precedes C4d deposition on extracellular neurofibrillary tangles. Acta Neuropathol (Berl) 1997; 93: 87-92.
29. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 1971; 19: 1-8.
30. Lauckner J, Frey P, Geula C. Comparative distribution of tau phosphorylated at Ser262 in pre-tangles and tangles. Neurobiol Aging 2003; 24: 767-776.
31. Dani SU, Pittella JE, Hori A, Bergmann B, Stan AC, Walter GF. Different rates of neuronal degeneration: an exquisite variation of the 'Cascade' hypothesis. Dementia 1994; 5: 110-118.
32. Dani SU, Pittella JE, Boehme A, Hori A, Schneider B. Progressive formation of neuritic plaques and neurofibrillary tangles is exponentially related to age and neuronal size. A morphometric study of three geographically distinct series of aging people. Dement Geriatr Cogn Disord 1997; 8: 217-227.
33. Vogt BA, Vogt LJ, Vrana KE et al. Multivariate analysis of laminar patterns of neurodegeneration in posterior cingulate cortex in Alzheimer's disease. Exp Neurol 1998; 153: 8-22.
34. Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992; 256: 184-185.
35. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 2003; 24: 1063-1070.
36. Park HJ, Seong YM, Choi JY, Kang S, Rhim H. Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi. Neurosci Lett 2004; 357: 63-67.
37. 40, in sporadic and familial Alzheimer's disease. Neuropathol Appl Neurobiol 2003; 29: 35-44.
38. Ferrer I, Boada Rovira M, Sanchez Guerra ML, Rey MJ, Costa-Jussá F. Neuropathology and pathogenesis of encephalitis following amyloid-immunization in Alzheimer's disease. Brain Pathol 2004; 14: 11-20.
39. Nicoll JAR, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO. Neuropathology of human Alzheimer disease after immunization with amyloid-peptide: a case report. Nat Med 2003; 9: 448-452.
40. Schukla C, Bridges LR. Regional distribution of tau, β-amyloid and β-amyloid precursor protein in the Alzheimer's brain: a quantitative immunolabeling study. Neuroreport 1999; 10: 3785-3789.
41. Thal DR, Rub U, Schultz C et al. Sequence of A beta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 2000; 59: 733-748.
42. Kobayashi K, Nakano H, Hayashi M et al. Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease. J Neurol Sci 2003; 208: 17-24.
43. Kobayashi K, Hayashi M, Nakano H et al. Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease. Neuropathol Appl Neurobiol 2002; 28: 238-251.
44. Mirra SS, Heyman A, McKeel D et al. The Consortium to Establish a Registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
45. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985; 42: 1097-1105.
46. Tomasiewicz HG, Wood JG. Characterization of microtubule-associated proteins in teleosts. Cell Motil Cytoskeleton 1999; 44: 155-167.
47. Iqbal K, Braak E, Braak H, Zaidi T, Grundke-Iqbal I. A silver impregnation method for labeling both Alzheimer paired helical filaments and their polypeptides separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Neurobiol Aging 1991; 12: 357-361.
48. Bussière T, Gold G, Kövari E et al. Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease. Neuroscience 2003; 117: 577-592.
49. Hof PR, Bouras C, Buee L, Delacourte A, Perl DP, Morrison JH. Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease. Acta Neuropathol (Berl) 1992; 85: 23-30.
50. Li F, Iseki E, Odawara T, Kosaka K, Yagishita S, Amano N. Regional quantitative analysis of tau-positive neurons in supranuclear palsy: comparison with Alzheimer's disease. J Neurol Sci 1998; 159: 73-81.
51. Fukutani Y, Kobayashi K, Nakamura I, Watanabe K, Isaki K, Cairns NJ. Neurons, intracellular and extracellular neurofibrillary tangles in subdivisions of the hippocampal cortex in normal ageing and Alzheimer's disease. Neurosci Lett 1995; 200: 57-60.
52. Garcia-Sierra F, Wischik CM, Harrington CR, Luna-Munoz J, Mena R. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease. J Chem Neuroanat 2001; 22: 65-77.
53. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997; 18: 351-357.
54. Hall GF, Lee VM, Lee G, Yao J. Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy. Am J Pathol 2001; 158: 235-246.
55. Morsch R, Simon W, Coleman PD. Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol 1999; 58: 188-197.
56. Schwab C, Schulzer M, Steele JC, McGeer PL. On the survival time of a tangled neuron in the hippocampal CA4 region in parkinsonism dementia complex of Guam. Neurobiol Aging 1999; 20: 57-63.